6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      Call for Papers in Kidney and Blood Pressure ResearchKidney Function and Omics Science

      Submission Deadline: December 20, 2023

      Submit now

      • Record: found
      • Abstract: found
      • Article: found

      Successful in situ Treatment of a Fungal Peritonitis during CAPD

      case-report
      , , , , ,
      Nephron
      S. Karger AG
      CAPD, Fungus, Peritonitis, 5-Fluorocytosine

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A case of Candida peritonitis during continuous ambulatory peritoneal dialysis (CAPD) which recovered with intraperitoneal 5-fluorocytosine alone is reported. This seems to be the first case of fungal peritonitis during CAPD without removing the catheter to be described in the literature.

          Related collections

          Author and article information

          Journal
          NEF
          Nephron
          10.1159/issn.1660-8151
          Nephron
          S. Karger AG
          1660-8151
          2235-3186
          1984
          1984
          04 December 2008
          : 37
          : 1
          : 66-67
          Affiliations
          Nephrology Department (Prof.: D. Fries), Faculté de Médecine Paris-Sud, Hôpital Paul-Brousse, Villejuif, France
          Article
          183212 Nephron 1984;37:66–67
          10.1159/000183212
          6717707
          4dc959ca-f177-4c15-9e35-17da98e1b769
          © 1984 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 20 July 1983
          Page count
          Pages: 2
          Categories
          Short Communication

          Cardiovascular Medicine,Nephrology
          CAPD,Peritonitis,Fungus,5-Fluorocytosine
          Cardiovascular Medicine, Nephrology
          CAPD, Peritonitis, Fungus, 5-Fluorocytosine

          Comments

          Comment on this article